August 5, 2026
Expedition Therapeutics
- Round
- Series B
- Amount raised
- $115M
- Lead investor
- General Atlantic
- Industry
- Biotechnology Research
- Headquarters
- —
- Employees
- 2-10 employees
- Website
- —
- View profile →
Other investors
- RA Capital
- Vivo Capital
- Sofinnova Investments
- Novo Holdings
- Forbion
- Dawn Biopharma
- Adage Capital Management
- Balyasny Asset Management
- Logos Capital
- Sanofi Ventures
- BVF Partners
- Venrock Healthcare Capital Partners
Source: FinSMEs